• Study on the Effects and Safety of RO7204239 for Patients with Facioscapulohumeral Muscular Dystrophy

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Italy

  • Study on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren’s Syndrome

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Greece Italy The Netherlands Norway Spain +1

  • Study of Afamelanotide for Patients with Erythropoietic Protoporphyria (EPP)

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium The Netherlands

  • Study on the Safety of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1
    Investigated Diseases:
    Croatia Cyprus Greece Spain

  • Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia France Germany +6

  • Study of Amivantamab with Carboplatin and Pemetrexed for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Hungary Italy Poland +2

  • Study of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark Estonia France +12

  • Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland Germany +7

  • Study of Sacituzumab Govitecan, Zimberelimab, and Domvanalimab for Patients with Muscle Invasive Bladder Cancer Ineligible for Cisplatin Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Spain

  • Study of Pembrolizumab for Patients with Locally Advanced, Unresectable, Non-Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

powered by